Gregory Mullen

Gregory Mullen

Company: Ariceum Therapeutics

Job title: Chief Operating Officer

Seminars:

Understanding Radionuclide Auger Therapy to Examine Its Use & Advantages 1:30 pm

• Identifying which radioisotopes can be used for Auger therapy • Overview of Auger therapies to date • Examining Auger PARP inhibitor radionuclide therapyRead more

day: Conference Day 2

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.